Insurtech companies had a record setting year in 2021 in terms of fundraising and valuations. This may be difficult to replicate with rising interest rates and the challenges publicly traded insurtechs are facing. S&P Global contacted Dr. Robert Hartwig who said rising interest rates are becoming a “reality check” for venture capital investors. Furthermore, Hartwig noted that it should have been “patently obvious” in 2021 that insurtechs carried “insane” valuations, and that investors and insurtechs were in the “midst of a bubble at risk of imminent collapse.” Read the article here.